These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5440596)

  • 1. Cephaloridine serum levels in patients on maintenance haemodialysis.
    Curtis JR; Marshall MJ
    Br Med J; 1970 Apr; 2(5702):149-51. PubMed ID: 5440596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjustment of cephaloridine (Keflodin): dosage according to its pharmacokinetics.
    Brogard JM; Brandt C; Dorner M; Dammron A
    Chemotherapy; 1976; 22(1):1-11. PubMed ID: 1253626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cephaloridine. Adjustment of its dosage to the degree of renal insufficiency and administration during chronic uremia treated by repeated hemodialysis].
    Brogard JM; Ruscher H; Frankhauser J; Jahn H; Dammron A
    Ann Med Interne (Paris); 1970 Dec; 121(12):1027-38. PubMed ID: 5504233
    [No Abstract]   [Full Text] [Related]  

  • 4. Half-life of cephaloridine in dogs with reduced renal function.
    Klausner JS; Meunier PC; Osborne CA; Stevens JB; Stowe CM
    Am J Vet Res; 1977 Aug; 38(8):1191-5. PubMed ID: 911088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serum half-life and urine concentrations of cephazolin sodium in patients with terminal renal failure: effect of haemodialysis.
    Eastwood JB; Gower PE; Curtis JR
    Scott Med J; 1976 Sep; 20(5):240-3. PubMed ID: 1265473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of cephalothin and cephloridine in uremic patients with hemodialysis].
    Takayasu H; Kitagawa R; Miyamura R; Koiso K; Kano S
    Saishin Igaku; 1971 Jun; 26(6):1173-7. PubMed ID: 5098182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic therapy and renal insufficiency. Pharmacokinetics of pivampicillin, cephaloridin and streptomycin in chronic uremic patients undergoing conservative or hemodialytic treatment].
    Campanacci L; Huber W; Bertoli M; Cancarini GC; Toigo G
    Minerva Med; 1975 Oct; 66(68):3547-65. PubMed ID: 1187001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function.
    Brown PH; Kalra PA; Turney JH; Cooper EH
    Nephrol Dial Transplant; 1988; 3(2):169-73. PubMed ID: 2459634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cephaloridine serum levels after intravenous injection.
    Mathews DD
    J Antimicrob Chemother; 1975; 1(3 Suppl):37-40. PubMed ID: 1201980
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D; Borner K; Pustelnik A
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and removal of metronidazole in patients undergoing haemodialysis.
    Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
    Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of antibiotics during peritoneal dialysis in patients with renal failure.
    Buck AC; Cohen SL
    J Clin Pathol; 1968 Jan; 21(1):88-92. PubMed ID: 4301499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on cephaloridine concentration in bone marrow (author's transl)].
    Kawashima M; Torisu T
    Jpn J Antibiot; 1977 Apr; 30(4):278-80. PubMed ID: 864857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.
    Riva E; Fossali E; Bettinelli A
    Eur J Clin Pharmacol; 1982; 21(4):303-6. PubMed ID: 7056274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of nails apparently induced by the administration of large amounts of cephaloridine and cloxacillin in two anephric patients.
    Eastwood JB; Curtis JR; Smith EK; De Wardener HE
    Br J Dermatol; 1969 Oct; 81(10):750-2. PubMed ID: 5379864
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy with cephaloridine in renal impairment.
    Bechtol LD
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):790-800. PubMed ID: 4629818
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cephaloridine in reduced kidney function].
    Neuhaus G; Willbrandt R; Fritz KW; Lange A; Volkening R
    Med Welt; 1971 Jul; 22(29):1209-12. PubMed ID: 5566157
    [No Abstract]   [Full Text] [Related]  

  • 20. Age-dependent renal accumulation of cephaloridine in the rabbit.
    Wold JS; Turnipseed SA
    Drug Metab Dispos; 1978; 6(1):87-90. PubMed ID: 23280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.